
Cardiovascular

Global Biotechnology Insights
May 5, 2020

Devices Improving Standard of Care for Cardiovascular Disease Patients
Given the considerable impact that CVD has on many people's lives, it is no surprise that the demand for solutions is exploding. IDTechEx Research found that the market for cardiovascular disease technology will exceed $40 billion by the year 2030.
Global Biotechnology Insights
Mar 6, 2020

Technologies for the Future of Healthcare
IDTechEx identifies top future technologies in healthcare. With demographic changes such as the aging of the population, they forecast there to be strong growth in technologies that help healthcare providers manage the growing burden on the healthcare system while maintaining high quality care.
Global Biotechnology Insights
Feb 7, 2020

Remote Patient Monitoring is the Future of CVD Management
Cardiovascular disease (CVD) must be better managed for patient care to improve. The protocols for monitoring patients are rapidly evolving. Historically, patients who fall ill are required to travel in order to visit a general practitioner or hospital. This procedure may soon become a thing of the past.
Global Biotechnology Insights
Jan 14, 2020

Diagnosing Cardiovascular Disease
Diagnosing CVD is the first step in patients' road to recovery. It is imperative to detect the disease early in order to administer treatment while it is still treatable. In addition, preventing the disease altogether is becoming more important in healthcare. The main approaches for detecting CVD are currently in vitro diagnostics (IVD) at point-of-care (POC) and the use artificial intelligence (AI) in cardiovascular imaging.
IDTechEx Research Subscribers

Cardiovascular monitoring via skin patches
Mobile cardiac telemetry (MCT), Holter monitoring, event monitoring and a comparison with other options
Global Biotechnology Insights
May 5, 2020

Devices Improving Standard of Care for Cardiovascular Disease Patients
Given the considerable impact that CVD has on many people's lives, it is no surprise that the demand for solutions is exploding. IDTechEx Research found that the market for cardiovascular disease technology will exceed $40 billion by the year 2030.
Global Biotechnology Insights
Feb 7, 2020

Remote Patient Monitoring is the Future of CVD Management
Cardiovascular disease (CVD) must be better managed for patient care to improve. The protocols for monitoring patients are rapidly evolving. Historically, patients who fall ill are required to travel in order to visit a general practitioner or hospital. This procedure may soon become a thing of the past.
IDTechEx Research Subscribers

Cardiovascular monitoring via skin patches
Mobile cardiac telemetry (MCT), Holter monitoring, event monitoring and a comparison with other options
Global Biotechnology Insights
Mar 6, 2020

Technologies for the Future of Healthcare
IDTechEx identifies top future technologies in healthcare. With demographic changes such as the aging of the population, they forecast there to be strong growth in technologies that help healthcare providers manage the growing burden on the healthcare system while maintaining high quality care.
Global Biotechnology Insights
Jan 14, 2020

Diagnosing Cardiovascular Disease
Diagnosing CVD is the first step in patients' road to recovery. It is imperative to detect the disease early in order to administer treatment while it is still treatable. In addition, preventing the disease altogether is becoming more important in healthcare. The main approaches for detecting CVD are currently in vitro diagnostics (IVD) at point-of-care (POC) and the use artificial intelligence (AI) in cardiovascular imaging.